Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections

Journal of Chemotherapy

Volumn 16, Issue 3, 2004, Pages 282-287

  Tascini, C ^a   Gemignani, G ^a   Ferranti, S ^a   Tagliaferri, E ^a   Leonildi, A ^a   Lucarini, A ^a   Menichetti, F ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Colistin; P. aeruginosa; Rifampin; Synergistic activity

Indexed keywords

AMIKACIN; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; METHYLPREDNISOLONE; PIPERACILLIN; RIFAMPICIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CASE REPORT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; GRAM NEGATIVE INFECTION; HEMOLYTIC ANEMIA; HUMAN; IN VITRO STUDY; LUNG ABSCESS; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMONIA; PSEUDOMONAS AERUGINOSA; TREATMENT OUTCOME; URETHRITIS; URINARY TRACT INFECTION;

EID: 3843060294     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.3.282     Document Type: Article

References (24)

1. Burwen DR, Banerjee SN, Gaynes RP and the National Nosocomial Infections Surveillance System. Ceftazidime resistance among selected nosocomial gram negative bacilli in the United States. J Infect Dis 1994; 170: 1622-5.
2. Gerding DN, Larson TA, Hughes LA et al. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 1991; 35: 1284-90.
3. Saiman L, Mehar F, Niu WW et al. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis 1996; 23: 532-7.
4. Cappelletty DM, Rybak MJ. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996; 40: 677-83.
5. Baltch AL, Bassey MC, Hammer RP, et et al. Synergy with cefsulodin or piperacillin and three aminoglycosides or aztreonam against aminoglycoside resistant strains of Pseudomonas aeruginosa. J Antimicrob Chemother 1991; 27: 801-8.
6. Chin NX, Neu HC. Synergy of new C-3 substituted cephalosporins and tobramycin against Pseudomonas aeruginosa and Pseudomonas cepacia. Diagnost Microbiol Infect Dis 1992; 12: 343-9.
7. Tascini C, Menichetti F, Bozza S, Del Favero A, Bistoni F. Evaluation of the activities of two-drug combinatios of rifampin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii. J Antimicrob Chemother 1998; 42: 270-1.
8. Tascini C, Ferranti S, Messina F, Menichetti F. In vitro and in vivo synergistic activity of colistin, rifampin and amikacin against a multidrug resistant Pseudomonas aeruginosa isolate. Clin Microbiol Infect 2000; 6: 690-1.
9. Levin AS, Barone AA, Penco J, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999; 28: 1008-11.
10. Thornsberry C, Hill BC, Swenson JM, McDougal LK. Rifampin: spectrum of antibacterial activity. Rev Infect Dis 1983; 5: S412-7.
11. th. ed. Approved guideline. Document M2-A6. National Committee for Clinical Laboratory Standards, Villanova, Pa, 1997.
12. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxyn B and colistin: review of available interpretative criteria and quality control guidelines. Antimicrob Agents Chemother 2001; 39: 183-90.
13. National Committee for Clinical Laboratory Standards. Performance standard for antimicrobial susceptibility testing. Document M100-S10. National Committee for Clinical Laboratory Standards, Villanova, Pa, 2000.
14. National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline. Document M26-P. National Committee for Clinical Laboratory Standards, Villanova, Pa, 1987.
15. Marques MB, Brookings ES, Moser A, et al. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations. Antimicrob Agents Chemother 1997; 41: 881-5.
16. Cappelletty DM, Rybak MJ. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996; 40: 677-83.
17. Evans ME, Feola DJ, Rapp RP. Polymyxin B sulphate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother 1999; 33: 960-967.
18. Paterson DL, Comaglia G, Mazzariol A, Lamonaca V, Gruttadauria S, Marino I. A true return to the pre-antibiotic era? Endovascular infections as sequelae of bacteremia with Pseudomonas aeruginosa producing VIM-1, resistant to carbapenems, chephalosporins, penicillins, quinolones and aminoglycosides. In Program and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, MI, 2002. Abstract K1183, p. 406. American Society for Microbiology, Washington, DC.
19. MacGowan AP, Rynn C, Wootton M, Bowker KE, Holt HA, Reeves DS. In vitro assessment of colistin's antimicrobial interactions with six other antimicrobials studied using a representative strain of P. aeruginosa. Clin Microbiol Infect 1999; 5: 37-46.
20. Vaara M. The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide. Drug Exp Clin Res 1991; 17: 437-43.
21. Linden PK, Kuene S, Coley K, Fontes P, Kramer DJ, Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 2003; 37: 154-160.
22. Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989; 87: 540-546.
23. Rynn C, Wootton M, Bowker KE et al. In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibiotics. Clin Microbiol Infect 1999; 5: 32-36.
24. Giamarellou-Barboulis EJ, Sambatakou H, Galani I et al. In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa. J Chemother 2003; 15: 235-238.